At Alexion, Corporate Social Responsibility (CSR) is an inherent part of everything we do and fundamental to helping us become the leader in rare disease. CSR is a guide to finding value in the actions we take each day as we work toward our mission of transforming the lives of people affected by rare diseases and devastating conditions.
Alexion is proud to have its New Haven, CT and Bogart, GA sites recognized by OSHA (Occupational Safety and Health Administration) for their commitment to workplace health and safety. Both sites participated in OSHA’s Safe + Sound Week, which incorporated fun virtual activities that helped to highlight Alexion’s strong culture of safety, including ways to be #SafeAndSoundAtWork and creating a pledge to practice safety at work.
The Alexion PharmD Fellowship Program, in conjunction with MCPHS University, is one of the avenues through which Alexion grows young talent. Throughout this 2-year fellowship, recently graduated PharmD’s complete rotations in multiple functional areas under qualified preceptors. The purpose of this highly competitive program is to prepare PharmD’s for a career in the biopharmaceutical industry.
Alexion is proud to support the National Association for the Advancement of Colored People (NAACP) by investing in the NAACP Empowerment Programs. Their mission of securing the political, educational, social, and economic equality of rights in order to eliminate racism and ensure the health and well-being of all persons aligns with our focus, culture and values at Alexion.
Advancing the emotional well-being of the rare disease community, our employees, and the communities in which we live, and work is a core commitment of ours. During Mental Health Awareness Month, we strengthened this commitment by joining One Mind at Work, a global coalition of employers deploying best practices for workplace brain health through our partnership with One Mind.
The current global pandemic has had a profound impact on many communities around the world, arguably the most profound being on the senior citizen community. During a recent day off, three of Alexion’s employees in Japan volunteered their time to virtually visit nursing home residents. Using Zoom to facilitate the visits, volunteers and seniors hit it off with jokes, laughs, and conversations about their hobbies and interests, as well as current events.
Alexion is committed to serving local communities through volunteerism, even when circumstances do not allow us to do so in person. In response to the COVID-19 pandemic and local stay-at-home orders, Alexion has begun offering virtual volunteering opportunities to employees.
Funding supports efforts by National Organization for Rare Disorders (NORDⓇ) and Global Genes to address needs of the rare disease community arising from COVID-19 pandemic
BOSTON, June 24, 2020 /3BL Media/ -- The Alexion Charitable Foundation, launched by Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) in February 2020, has announced it has awarded a total of $1.1 million in initial grants that align with its Rare Belonging® focus. Rare Belonging seeks to advance emotional well-being and educational opportunities, and provide relief for critical needs, for those living with or affected by a rare disease.
A healthy planet is essential in securing a brighter future for both present and future generations. We’re committed to excellence in managing and reducing our environmental footprint.
Endorsed by our CEO, our Environmental, Health and Safety (EHS) Policy emphasizes our commitment to environmental stewardship and the health and safety of our colleagues and communities. All employees and contractors are covered by this Policy.